Mergers & AcquisitionsMedium•17 November 2026•
1 min read
Rythm Pharmaceuticals Shares Rise on Reported Eli Lilly Buyout Offer

Key Facts
1Rythm Pharmaceuticals shares gained following reports that Eli Lilly made a $150 per share buyout offer.
2The alleged acquisition offer includes a Contingent Value Right (CVR) in addition to the cash price.
Rythm Pharmaceuticals shares gained following reports that Eli Lilly made a $150 per share buyout offer. Seeking Alpha reported that the alleged acquisition proposal includes a Contingent Value Right (CVR) in addition to the cash price.
LLY was trading at $1415.57 on November 17, 2026, reaching a session high of $1432.27. The reported offer signals Eli Lilly's continued expansion strategy within the pharmaceutical sector through potential multi-billion dollar acquisitions.